Venosum Biotech

Venosum: Pioneering the Future of Medicine through Bio-Innovation

Venosum is a dynamic biotechnology firm operating at the intersection of nature's potent chemistry and cutting-edge oncology research. We are dedicated to harnessing the extraordinary therapeutic potential of scorpion venom—a complex, peptide-rich biological resource—to develop the next generation of life-saving cancer treatments.

Our Core Mission

We believe that nature holds the key to the future of medicine. Our mission is two-fold:

Sustainable Production: To ethically and technologically advance the production of high-purity, standardized scorpion venom peptides for global research and pharmaceutical applications.

Oncology Innovation: To rigorously explore, isolate, and develop novel bio-compounds from this venom, focusing on targeted therapies that offer higher efficacy and lower toxicity against various cancer types.

Why Scorpion Venom?

Scorpion venom peptides have demonstrated remarkable selectivity, targeting cancer cells while leaving healthy cells largely untouched. At Venosum, our world-class team of biologists, toxicologists, and oncologists is decoding this specificity to create precision medicine solutions for a global patient population.

Global Impact & Collaboration

Our vision extends beyond the lab. We are committed to fostering international scientific collaboration and setting new global standards for venom-based drug discovery. We invite researchers, investors, and partners who share our passion for bio-innovation to join us in transforming the fight against cancer.

Venosum: Where Nature’s Complexity Meets Medical Breakthroughs.